A Phase 2/3 Multicenter, Controlled Trial Of rhBMP-2/CPM In Tibial Fractures
Clinical trial NCT00387686 · TERMINATED
Trial details
- NCT number
- NCT00387686
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2009-07-01
- Enrollment
- 367
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.